These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 16214079)
21. Gene transfer of human TCR in primary murine T cells is improved by pseudo-typing with amphotropic and ecotropic envelopes. Pouw NM; Westerlaken EJ; Willemsen RA; Debets R J Gene Med; 2007 Jul; 9(7):561-70. PubMed ID: 17471588 [TBL] [Abstract][Full Text] [Related]
22. Breast cancer immunotherapy. Zhou J; Zhong Y Cell Mol Immunol; 2004 Aug; 1(4):247-55. PubMed ID: 16225767 [TBL] [Abstract][Full Text] [Related]
23. Alphabeta T-cell receptor engineered gammadelta T cells mediate effective antileukemic reactivity. van der Veken LT; Hagedoorn RS; van Loenen MM; Willemze R; Falkenburg JH; Heemskerk MH Cancer Res; 2006 Mar; 66(6):3331-7. PubMed ID: 16540688 [TBL] [Abstract][Full Text] [Related]
24. Defect in TCR-CD3zeta signaling mediates T cell hypo-responsiveness in mesenteric lymph node. Yi HJ; Lee CG; Kwon HK; So JS; Sahoo A; Hwang JS; Jash A; Hwang KC; Im SH Mol Immunol; 2008 Aug; 45(14):3748-55. PubMed ID: 18619676 [TBL] [Abstract][Full Text] [Related]
25. Disruption of T cell regulatory pathways is necessary for immunotherapeutic cure of T cell acute lymphoblastic leukemia in mice. Fiorentino S; Chopin M; Dastot H; Boissel N; Reboul M; Legrès L; Janin A; Aplan P; Sigaux F; Regnault A Eur Cytokine Netw; 2005 Dec; 16(4):300-8. PubMed ID: 16464745 [TBL] [Abstract][Full Text] [Related]
26. Full activation of the T cell receptor requires both clustering and conformational changes at CD3. Minguet S; Swamy M; Alarcón B; Luescher IF; Schamel WW Immunity; 2007 Jan; 26(1):43-54. PubMed ID: 17188005 [TBL] [Abstract][Full Text] [Related]
27. Transfer of in vitro expanded T lymphocytes after activation with dendritomas prolonged survival of mice challenged with EL4 tumor cells. Li J; Theofanous L; Stickel S; Bouton-Verville H; Burgin KE; Jakubchak S; Wagner TE; Wei Y Int J Oncol; 2007 Jul; 31(1):193-7. PubMed ID: 17549421 [TBL] [Abstract][Full Text] [Related]
28. Reversal of the TCR stop signal by CTLA-4. Schneider H; Downey J; Smith A; Zinselmeyer BH; Rush C; Brewer JM; Wei B; Hogg N; Garside P; Rudd CE Science; 2006 Sep; 313(5795):1972-5. PubMed ID: 16931720 [TBL] [Abstract][Full Text] [Related]
29. Different lineages of P1A-expressing cancer cells use divergent modes of immune evasion for T-cell adoptive therapy. Bai XF; Liu JQ; Joshi PS; Wang L; Yin L; Labanowska J; Heerema N; Zheng P; Liu Y Cancer Res; 2006 Aug; 66(16):8241-9. PubMed ID: 16912204 [TBL] [Abstract][Full Text] [Related]
30. Adoptively transferred anti-CD3-activated T cells for human tumor immunotherapy. Gold JE J Clin Oncol; 1993 Sep; 11(9):1836-7. PubMed ID: 8355052 [No Abstract] [Full Text] [Related]
31. High-dose chemotherapy and adoptive immunotherapy in the treatment of recurrent pediatric brain tumors. Peres E; Wood GW; Poulik J; Baynes R; Sood S; Abidi MH; Klein J; Bhambhani K; Dansey R; Abella E Neuropediatrics; 2008 Jun; 39(3):151-6. PubMed ID: 18991194 [TBL] [Abstract][Full Text] [Related]
32. Use of recombinant lentivirus pseudotyped with vesicular stomatitis virus glycoprotein G for efficient generation of human anti-cancer chimeric T cells by transduction of human peripheral blood lymphocytes in vitro. Simmons A; Whitehead RP; Kolokoltsov AA; Davey RA Virol J; 2006 Feb; 3():8. PubMed ID: 16507098 [TBL] [Abstract][Full Text] [Related]
33. Antitumor activity and some immunological properties of gammadelta T-cells from patients with gastrointestinal carcinomas. Murayama M; Tanaka Y; Yagi J; Uchiyama T; Ogawa K Anticancer Res; 2008; 28(5B):2921-31. PubMed ID: 19031935 [TBL] [Abstract][Full Text] [Related]
34. Transgene-enforced co-stimulation of CD4+ T cells leads to enhanced and sustained anti-tumor effector functioning. Chang L; Chang WC; McNamara G; Aguilar B; Ostberg JR; Jensen MC Cytotherapy; 2007; 9(8):771-84. PubMed ID: 17917884 [TBL] [Abstract][Full Text] [Related]
35. Transfection of drug-specific T-cell receptors into hybridoma cells: tools to monitor drug interaction with T-cell receptors and evaluate cross-reactivity to related compounds. Schmid DA; Depta JP; Lüthi M; Pichler WJ Mol Pharmacol; 2006 Jul; 70(1):356-65. PubMed ID: 16617162 [TBL] [Abstract][Full Text] [Related]